comparemela.com
Home
Live Updates
PROs Underscore Utility of Mirvetuximab Soravtansine in FR&#
PROs Underscore Utility of Mirvetuximab Soravtansine in FR&#
PROs Underscore Utility of Mirvetuximab Soravtansine in FRα+ Ovarian Cancer
Gottfried E. Konecny, MD, discusses PRO data for mirvetuximab soravtansine derived from the phase 3 MIRASOL trial.
Related Keywords
Los Angeles ,
California ,
United States ,
Gottfriede Konecny ,
,
Health Jonsson Comprehensive Cancer Center ,
University Of California ,
Department Of Gynecologic Medical Oncology ,
Gynecologic Medical Oncology ,
Jonsson Comprehensive Cancer ,
D ,
Mirvetuximab Soravtansine ,
Mirasol Trial ,